
Please try another search
By Investing.com Staff
Stocks edged lower Tuesday as traders watch developments in China around protests over the county's 'zero COVID' policy. Amid the downside action, several rumors swirled around Wall Street. Below we highlight a few:
Horizon Therapeutics (NASDAQ:HZNP) surged 30% after hours after it confirmed that it is engaged in highly preliminary discussions with Amgen Inc . (NASDAQ:AMGN), Janssen Global Services, LLC (NYSE:JNJ) and Sanofi (NASDAQ:SNY) which may or may not lead to an offer being made for the entire share capital of the Company.
Fidelity National Information Services Inc (NYSE:FIS) gained 3% after analysts at Bernstein said the company was a good fit for an activist investor. The analysts see value creation from a potential divestiture of its merchant business, something an activist could push for.
Chart Industries (NYSE:GTLS) gained over 2% after analysts at Citi said Halliburton Company (NYSE:HAL) should take a large equity stake in the company as Chart needs cash to fund the recently announced $4.4 billion acquisition of Howden. "While the likelihood may be modest, serious consideration should occur," the analysts added.
Want to get this news first? Upgrade to InvestingPro for real-time market coverage.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.